Polycystic ovary syndrome and cardiometabolic risk: Opportunities for cardiovascular disease prevention

Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences

Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome